Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
26.62
+0.65 (2.50%)
May 6, 2026, 3:00 PM CST

Runben Biotechnology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,7709,8039,4477,356--
Market Cap Growth
-24.20%3.77%28.44%---
Enterprise Value
9,6298,6749,0546,808--
Last Close Price
26.6224.2323.0517.66--
PE Ratio
33.3031.1731.4732.54--
Forward PE
28.6224.6626.2726.80--
PS Ratio
6.856.357.177.12--
PB Ratio
4.744.414.543.83--
P/TBV Ratio
4.934.604.663.87--
P/FCF Ratio
61.2252.3151.6230.79--
P/OCF Ratio
36.9035.6236.7329.13--
EV/Sales Ratio
6.135.626.876.59--
EV/EBITDA Ratio
26.4924.4627.6225.94--
EV/EBIT Ratio
28.2225.9829.3828.06--
EV/FCF Ratio
54.7446.2849.4728.50--
Debt / Equity Ratio
00.000.000.000.010.02
Debt / EBITDA Ratio
0.000.000.010.020.040.07
Debt / FCF Ratio
0.010.010.020.020.06-
Net Debt / Equity Ratio
-0.50-0.53-0.69-0.83-0.51-0.45
Net Debt / EBITDA Ratio
-3.15-3.31-4.36-6.09-1.89-1.82
Net Debt / FCF Ratio
-6.49-6.27-7.82-6.69-2.9618.84
Asset Turnover
0.660.680.620.731.161.26
Inventory Turnover
3.515.395.234.644.935.40
Quick Ratio
7.5810.6110.5816.933.973.64
Current Ratio
10.9814.5311.6318.045.284.56
Return on Equity (ROE)
14.69%14.62%15.00%17.10%24.93%29.72%
Return on Assets (ROA)
9.01%9.16%9.09%10.66%15.06%17.69%
Return on Invested Capital (ROIC)
27.41%34.18%54.09%60.54%45.44%45.56%
Return on Capital Employed (ROCE)
15.00%15.00%14.80%12.60%24.30%22.90%
Earnings Yield
3.00%3.21%3.18%3.07%--
FCF Yield
1.63%1.91%1.94%3.25%--
Dividend Yield
1.77%-1.78%0.96%--
Payout Ratio
54.56%56.02%45.32%-2.15%25.65%
Buyback Yield / Dilution
0.87%0.60%-14.85%-3.71%-1.61%-9.69%
Total Shareholder Return
2.64%0.60%-13.07%-2.75%-1.61%-9.69%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.